- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03081403
Quantitative Sensory Testing in Subjects With Sensitive Skin or Not (SENSISKIN)
Sensitive skin is a common problem, with 50% of women and 30% of men in Europe feel they have sensitive skin.
The Quantitative sensory testing (QST) is a physico-psychic method that uses gradients stimuli of different modalities to measure a subjective somatosensory response. This allows to characterize sensory dysfunction by assessing the participation of small and large nerve fibers.
The aim of this project is to characterize the presence or absence of a neurological disorder in patients with sensitive skin. This discovery would be a decisive argument to reinforce the suspicion that sensitive skins is linked to a small fiber neuropathy.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Sensitive skin is a common problem, with 50% of women and 30% of men in Europe feel they have sensitive skin. A sensitive skin is characterized by the occurrence of tingling sensations, tightness, heat, burning, itching or pain triggered by non pathogenic factors such as wind, heat, cold, water , cosmetics, toiletries, stress...
The Quantitative sensory testing (QST) is a physico-psychic method that uses gradients stimuli of different modalities to measure a subjective somatosensory response. This allows to characterize sensory dysfunction by assessing the participation of small and large nerve fibers.
The aim of this project is to characterize the presence or absence of a neurological disorder in patients with sensitive skin. This discovery would be a decisive argument to reinforce the suspicion that sensitive skins is linked to a small fiber neuropathy.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Brest, France, 29200
- CHRU de Brest
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age: between 20 and 60 years
- Cooperating patient
- Informed and written consent of the subject
- Affiliated to the social security
- For subjects with sensitive skin:
subjects with a score greater than 50 on the scale sensitive scale
- To control subjects: subjects with result of less than 20 sensitive to the scale scale
Exclusion Criteria:
- Adults subject with legal protection
- Subject in a social institution.
- Subject with major cognitive or psychiatric disorders
- Subject with pathological use of alcohol or consumption of another drug.
- Subject with skin involvement of the back of the dominant hand or malformation.
- Known sensitive neuropathy
- Pregnant woman
- Subject receiving medical treatment which may interfere with the results.
- Subject with treatment in the back of the dominant hand.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Subjects with sensitive skin
Subjects with a score greater than 50 on the sensitive scale
|
Study of detection thresholds of vibration, cold and pain related to the heat in the dominant hand of the subjects through the QST.
|
|
Other: Subjects without sensitive skin
Subjects with result lower than 20 on the sensitive scale
|
Study of detection thresholds of vibration, cold and pain related to the heat in the dominant hand of the subjects through the QST.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cutaneous perception threshold
Time Frame: 6 months
|
The cutaneous perception threshold of pain to heat.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The cutaneous perception threshold of vibration
Time Frame: 6 months
|
The cutaneous perception threshold of pain to harm.
|
6 months
|
|
The cutaneous perception threshold of cold
Time Frame: 6 months
|
The cutaneous perception threshold of cold
|
6 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SENSISKIN 29CRB16.0100
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sensitive Skin
-
Kenvue Brands LLCCompletedSensitive Skin | Non-sensitive SkinUnited States
-
NovoBliss Research Pvt LtdKayura Effects LLPCompleted
-
NovoBliss Research Pvt LtdKayura Effects LLPCompleted
-
SAVA Healthcare LimitedNot yet recruiting
-
Derming SRLCompleted
-
University Hospital, BrestCompletedSensitive SkinFrance
-
Shanghai Dermatology HospitalRecruiting
-
NovoBliss Research Pvt LtdSkin Harmony Lifescience Pvt. LtdNot yet recruitingSensitive Skin | Normal
-
NovoBliss Research Pvt LtdGlowderma Lab Private LimitedCompleted
-
University Hospital, BrestCompletedSensitive Skin | Cosmetic ExposureFrance
Clinical Trials on Quantitative Sensory Testing
-
University GhentRecruiting
-
Universitaire Ziekenhuizen KU LeuvenCompleted
-
Walton Centre NHS Foundation TrustActive, not recruitingFacial PainUnited Kingdom
-
Spine Centre of Southern DenmarkUniversity of Southern DenmarkCompleted
-
University of Sao PauloCompletedNeuralgia | Facial Pain | Comorbidity
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI)Recruiting
-
Julia FinkelCompletedSCD With Severe Phenotype (HbSS, HbSβ0 Thalassemia, HbSOARab)United States
-
Region Örebro CountyAalborg UniversityCompleted
-
University of California, Los AngelesCompleted